
Medical Developments International Ltd
ASX:MVP

Medical Developments International Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.39
0.91
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Medical Developments International Ltd hold over its rivals?
What risks and challenges
does Medical Developments International Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Medical Developments International Ltd.
Provide an overview of the primary business activities
of Medical Developments International Ltd.
What unique competitive advantages
does Medical Developments International Ltd hold over its rivals?
What risks and challenges
does Medical Developments International Ltd face in the near future?
Has there been any significant insider trading activity
in Medical Developments International Ltd recently?
Summarize the latest earnings call
of Medical Developments International Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Medical Developments International Ltd.
Provide P/S
for Medical Developments International Ltd.
Provide P/E
for Medical Developments International Ltd.
Provide P/OCF
for Medical Developments International Ltd.
Provide P/FCFE
for Medical Developments International Ltd.
Provide P/B
for Medical Developments International Ltd.
Provide EV/S
for Medical Developments International Ltd.
Provide EV/GP
for Medical Developments International Ltd.
Provide EV/EBITDA
for Medical Developments International Ltd.
Provide EV/EBIT
for Medical Developments International Ltd.
Provide EV/OCF
for Medical Developments International Ltd.
Provide EV/FCFF
for Medical Developments International Ltd.
Provide EV/IC
for Medical Developments International Ltd.
Show me price targets
for Medical Developments International Ltd made by professional analysts.
What are the Revenue projections
for Medical Developments International Ltd?
How accurate were the past Revenue estimates
for Medical Developments International Ltd?
What are the Net Income projections
for Medical Developments International Ltd?
How accurate were the past Net Income estimates
for Medical Developments International Ltd?
What are the EPS projections
for Medical Developments International Ltd?
How accurate were the past EPS estimates
for Medical Developments International Ltd?
What are the EBIT projections
for Medical Developments International Ltd?
How accurate were the past EBIT estimates
for Medical Developments International Ltd?
Compare the revenue forecasts
for Medical Developments International Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Medical Developments International Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Medical Developments International Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Medical Developments International Ltd compared to its peers.
Compare the P/E ratios
of Medical Developments International Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Medical Developments International Ltd with its peers.
Analyze the financial leverage
of Medical Developments International Ltd compared to its main competitors.
Show all profitability ratios
for Medical Developments International Ltd.
Provide ROE
for Medical Developments International Ltd.
Provide ROA
for Medical Developments International Ltd.
Provide ROIC
for Medical Developments International Ltd.
Provide ROCE
for Medical Developments International Ltd.
Provide Gross Margin
for Medical Developments International Ltd.
Provide Operating Margin
for Medical Developments International Ltd.
Provide Net Margin
for Medical Developments International Ltd.
Provide FCF Margin
for Medical Developments International Ltd.
Show all solvency ratios
for Medical Developments International Ltd.
Provide D/E Ratio
for Medical Developments International Ltd.
Provide D/A Ratio
for Medical Developments International Ltd.
Provide Interest Coverage Ratio
for Medical Developments International Ltd.
Provide Altman Z-Score Ratio
for Medical Developments International Ltd.
Provide Quick Ratio
for Medical Developments International Ltd.
Provide Current Ratio
for Medical Developments International Ltd.
Provide Cash Ratio
for Medical Developments International Ltd.
What is the historical Revenue growth
over the last 5 years for Medical Developments International Ltd?
What is the historical Net Income growth
over the last 5 years for Medical Developments International Ltd?
What is the current Free Cash Flow
of Medical Developments International Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Medical Developments International Ltd.
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
AU |
![]() |
Medical Developments International Ltd
ASX:MVP
|
64.2m AUD | -4.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
722.9B USD | 80.9 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 6 930.6 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
360.3B USD | 15 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 16.5 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.2B CHF | 11 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
185.9B CHF | 12.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161.1B GBP | 199.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
198.9B USD | 10.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 632.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.3B USD | 12.7 |
|
AU |
![]() |
Medical Developments International Ltd
ASX:MVP
|
Average EV/OCF:
792.2
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
80.9
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
6 930.6
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
15
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
16.5
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
11
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
12.8
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
199.1
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
10.7
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
632.4
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
12.7
|
|
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.